background
banner

INRAB 20 Price

Active Substance: Rabeprazole sodium.

45
UAD , based on 7541 reviews.
View Drug details

Overview

Welcome to Dwaey, specifically on INRAB 20 Tablets/Delayed Release page.
This medicine contains an important and useful components, as it consists of Rabeprazole sodium.
INRAB 20 is available in the market in concentration 20mg/Tablet and in the form of Tablets/Delayed Release.

AUROBINDO PHARMA LIMITED is the producer of INRAB 20 and it is imported from INDIA, The most popular alternatives of INRAB 20 are listed downward .

Mode Of Action

Rabeprazole is a PPI that suppresses gastric acid secretion by inhibiting H+/K+ ATPase at the secretory surface of the gastric parietal cell.

Indication

  • Peptic ulcer disease
  • H. pylori infection
  • Gastro-oesophageal reflux disease
  • Paediatric GERD

Precaution

Gastric malignancy should be ruled out. Severe hepatic impairment. Pregnancy and lactation. Monitoring Parameters Monitor Mg levels prior to initiation and periodically during prolonged use. Lactation: Unknown whether rabeprazole is distributed into breast milk; use caution

Side Effects

  • 1-10% Headache (2-10%)
  • Constipation (2%)
  • Diarrhea (2-5%)
  • Flatulence (3%)
  • Pain (3%)
  • Pharyngitis (3%)
  • Abdominal pain (4%) <1% Agitation
  • Agranulocytosis
  • Alopecia
  • Anemia
  • Angioedema
  • Chest pain
  • Delirium
  • Erythema
  • Hypokalemia
  • Hypomagnesemia
  • Hyponatremia
  • Jaundice
  • Leukocytosis
  • Leukopenia
  • Migraine
  • Osteoporosis related fracture
  • Rhabdomyolysis
  • Stevens-Johnson syndrome
  • Sudden death
  • Toxic epidermal necrolysis
  • Abnormal taste

Contra indication

Rabeprazole is contraindicated in patients with known hypersensitivity to Rabeprazole, other PPIs or to any component of the formulation.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Interaction

May decrease serum concentration of ketoconazole, itraconazole and clopidogrel. Increased risk of hypomagnesaemia w/ diuretics and digoxin. May increase prothrombin time and INR of warfarin. May increase plasma concentration of saquinavir and methotrexate. Decreased serum levels w/ sucralfate. Potentially Fatal: May decrease plasma concentrations and pharmacological effects of rilpivirine and atazanavir.

Alternatives Price List

  • ULCERBREX 20mgUAD 55
  • ULCERBREX 20mgUAD 97
  • RABEZOLE 20mgUAD 46
  • PARIET 20mgUAD 75
  • PARIET 20mgUAD 137

Releated Products

banner

Report Price Error

Please feel welcome to contact Us with any price or medical error. Our doctors will receive any reports.